Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The change in GLP-1 response was statistically significant at the 3-gram dose but not at the 1-gram dose
This is the four seasons of urgent care and IV therapy
GLP-1 medications should only be used under the supervision of a licensed healthcare provider
Supplementary information Supplementary Tables 16 and Note 1
Product Details Semaglutide OL 12.5mg 2.5mg/ml x 5ml Manufacturer: Olympia Pharmaceuticals MFG#: C21691 PID: 639310 Beyond Use Date (BUD): 10/05/2025 Additional Information Description Semaglutide OL 12.5 mg (2.5 mg/mL 5 mL) is a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily for the management of type 2 diabetes mellitus and chronic weight management
Careful screening for personal and familial risk factors for thromboembolism is recommended before initiation.[] The drug is contraindicated in the presence of coagulation disorders, pregnancy and lactation to avoid any catastrophe,[] although potentially life threatening side effects namely deep vein thrombosis, pulmonary embolism and myocardial infarction have not been reported at this low dose.[] However, a variable relapse rate ranging from 9 to 27% has been reported after stopping the medication.[] Glutathione Glutathione, a low molecular weight thiol-peptide plays an important role in maintaining the intracellular redox balance, itself being a powerful antioxidant
